Cross-membrane signal transduction of receptor tyrosine kinases (RTKs): From systems biology to systems pharmacology

Journal of Mathematical Biology

Volumn 66, Issue 4-5, 2013, Pages 719-742

  Benson, Neil ^a   van der Graaf, Piet H ^b   Peletier, Lambertus A ^c  

^a Xenologiq Ltd Unit 7   (United Kingdom)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^c LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Receptors; Signal transduction; Singular perturbation; Systems biology; Systems pharmacology; Tyrosine Kinase

Indexed keywords

EID: 84874209469     PISSN: 03036812     EISSN: 14321416     Source Type: Journal    
DOI: 10.1007/s00285-012-0620-z     Document Type: Article

References (20)

1. Aston PJ, Derks G, Raji A, Agoram BM, van der Graaf PH (2011) Mathematical analysis of the pharmacokinetic-pharmacodynamic (PKPD) behaviour of monoclonal antibodies: predicting in vivo potency. J Theor Biol 281: 113-121.
2. Benson N, Cucurull-Sanchez L, Demin O, Smirnov S, van der Graaf PH (2012) Reducing systems biology to practice in pharmaceutical company research; selected case studies. Adv Syst Biol 736: 607-615.
3. Fujioka A, Terai K, Itoh RE, Aoki K, Nakamura T, Kuroda S, Nishida E, Matsuda M (2006) Dynamics of the Ras/ERK MAPK cascade as monitored by fluorescent probes. J Biol Chem 281: 8917-8926.
4. Gibiansky L, Gibiansky E, Kakkar T, Ma P (2008) Approximations of the target-mediated drug disposition model and identifiability of model parameters. J Pharmacokinet Pharmacodyn 35: 573-591.
5. Groves PM, Rebec GV (1988) Introduction to biological psychology, 3rd edn. Wm. C. Brown Publ, Dubuque.
6. Hartwell LH, Hopfiels JJ, Leibler S, Murray AW (1999) From molecular to modular cell biology. Nature 402: C47-C52.
7. Haugh J, Lauffenburger DA (1998) Analysis of receptor internalisation as a mechanism of modulating signal transduction. J Theor Biol 195: 187-217.
8. Krippendorff BF, Oyarzuń D, Huisinga W (2009) Ligand accumulation counteracts therapeutic inhibition of receptor systems. Proceedings of foundations of systems biology in Engineering, pp 173-176.
9. Mager D (2006) Target-mediated drug disposition and dynamics. Biochem Pharmacol 72: 1-10.
10. Mager D, Jusko WJ (2001) General pharmacokinetic model for drugs exhibiting target-mediated drug disposition. J Pharmacokinet Phamacodyn 28: 507-532.
11. Peletier LA, Gabrielsson J (2009) Dynamics of target-mediated drug disposition. J Pharmacokinet Phamacodyn 38: 445-464.
12. Peletier LA, Gabrielsson J (2012) Dynamics of target-mediated drug disposition: characteristic profiles and parameter identification. J Pharmacokinet Phamacodyn 39: 429-451.
13. Robinson DR, Wu YM, Lin SF (2000) The protein tyrosine kinase family of the human genome. Oncogene 19: 5548-5557.
14. Rostami-Hodjegan A (2012) Physiologically based pharmacokinetics joined with in vitro-in vivo extrapolation of ADME: a marriage under the arch of systems pharmacology. Clin Pharmacol Ther 92: 50-61.
15. Sasagawa S, Ozaki Y-I, Fujita K, Kuroda S (2005) Prediction and validation of the distinct dynamics of transient and sustained ERK activation. Nat Cell Biol 7: 365-373.
16. Segel LA, Slemrod M (1989) The quasi-steady-state assumption: a case study in perturbation. SIAM Rev 31: 446-477.
17. Shankaran H, Resat H, Wiley HS (2007) Cell surface receptors for signal transduction and ligand transport: a design principles study. PLoS Comput Biol 3: 986-999.
18. van der Graaf PH (2012) CPT: pharmacometrics and systems pharmacology. CPT: Pharmacomet Syst Pharmacol 1: e1. doi: 10. 1038/psp. 2012. 8.
19. van der Graaf PH, Benson N (2011) Systems pharmacology: bridging systems biology and pharmacokinetics-pharmacodynamics (PKPD) in drug discovery and development. Pharm Res 28: 1460-1464.
20. Zweifel LS, Kuruvilla R, Ginty DD (2005) Functions and mechanisms of retrograde neurotrophin signalling. Nat Rev Neurosci 6: 615-625.